rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    RNTX
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Rein Therapeutics at Guggenheim conference: fibrosis bet advances
      Nov 9Investing.comRNTX
      Rein Therapeutics to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference
      Nov 2Yahoo FinanceRNTX
      What Makes Maze Therapeutics, Inc. (MAZE) a New Buy Stock
      Oct 19Yahoo FinanceMAZERNTX
      Rein Therapeutics at cantor global healthcare: ipf push gains traction
      Sep 11Investing.comRNTX
      Rein Therapeutics to Present Late-Breaking Poster at the European Respiratory Society (ERS) 2026 Congress

      AUSTIN, Texas, Sept. 04, 2026 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines in orphan pulmonary and fibrosis indications, today announced that it will present a late-breaking poster at the European Respiratory Society (ERS) 2026 Congress taking place September 5-9, 2026, in Barcelona, Spain. Poster Presentation Title: Inhaled LTI-03 for idiopathic pulmonary fibrosis: a randomized dose escalation s

      Sep 4Yahoo FinanceRNTX
      Rein Therapeutics to Present at Upcoming September Investor Conferences

      AUSTIN, Texas, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines in orphan pulmonary and fibrosis indications, today announced that Brian Windsor, President and Chief Executive Officer of Rein Therapeutics, will present at the following investor conferences in September. 2026 Cantor Global Healthcare Conference Date & Time: Friday, September 11, 2026, at 8:00 a.m. ETLocation: New York,

      Sep 3Yahoo FinanceRNTX
      Here's Why You Should Add RNTX Stock to Your Portfolio Now

      Rein Therapeutics advances LTI-03 in IPF. RENEW enrollment tops 25%, with interim data expected in the fourth quarter of 2026.

      Sep 3Yahoo FinanceRNTX
      Rein Therapeutics Receives Nasdaq Delisting Notice Over Bid Price

      Tipranks Press Release.

      Aug 28The Globe and MailRNTX

      This is the newest page. Registered accounts read further back.